Rapid Medical Donation Programme for Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients
- Status
- WITHDRAWN
- Phase
- N/A
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
- Status
- UNKNOWN
- Phase
- NA
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
- Status
- COMPLETED
- Phase
- PHASE2
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
- Status
- RECRUITING
- Phase
- NA
Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes
- Status
- UNKNOWN
- Phase
- N/A
BIG Molecular Screening Feasibility Study
- Status
- COMPLETED
- Phase
- NA
T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?
- Status
- COMPLETED
- Phase
- N/A
Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Biweekly Docetaxel in Patients With Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
- Status
- COMPLETED
- Phase
- PHASE1